Current Cardiovascular Risk Reports

, Volume 7, Issue 6, pp 514–519 | Cite as

Radiation Therapy and Cardiovascular Disease Risk in Breast Cancer

Game Changers in CV Risk Research (D Levy, Section Editor)

Abstract

The cardiovascular disease risk among the breast cancer population is becoming increasingly important as the population of long-term survivors continues to rise. Radiation therapy decreases local reoccurrence and improves overall survival. These benefits however are not met without challenges including the potential for an increased risk of developing cardiovascular disease. Early clinical trials demonstrate that cardiovascular mortality is increased following radiation therapy compared to those treated without radiation therapy. Cardiovascular disease morbidity is also associated with radiation therapy for women with breast cancer. Among those who are irradiated, potential risk factors including age, surgery type, left-sided disease, dose, and previous cardiovascular disease may increase the risk of developing fatal cardiovascular disease. Newer clinical trials are showing promising results, with a decline in cardiovascular disease risk among those treated with radiation therapy; however, longer-term follow up is needed to confirm these findings.

Keywords

Breast cancer Radiation therapy Cardiovascular disease Epidemiology 

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Canada S. Canadian Cancer Statistics Special topic: Liver cancer; 2013. p. 1–114.Google Scholar
  2. 2.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.PubMedCrossRefGoogle Scholar
  3. 3.
    Bouillon K, Haddy N, Delaloge S, Garbay J-R, Garsi J-P, Brindel P, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011;57(4):445–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Patnaik J, Byers T, DiGuiseppi C, Dabelea D, Denberg T. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.PubMedCrossRefGoogle Scholar
  5. 5.
    •• Hooning MJ, Aleman BMP, van Rosmalen AJM, Kuenen MA, Klijn JGM, van Leeuwen FE. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64(4):1081–91. This study defines the increased risk of developing cardiovascular disease among women treated with radiation therapy for breast cancer. These findings are based on women treated with older radiation techniques.Google Scholar
  6. 6.
    Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12(3):447–53.PubMedGoogle Scholar
  7. 7.
    Lin R, Tripuraneni P. Radiation therapy in early-stage invasive breast cancer. Indian J Surg Oncol. 2011;2(2):101–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312(11):674–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106.PubMedGoogle Scholar
  11. 11.
    Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353(9165):1641–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Violet JA. Breast cancer: improving outcome following adjuvant radiotherapy. Br J Radiol. 2004;77(922):811–20.PubMedCrossRefGoogle Scholar
  13. 13.
    Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial. J Natl Cancer Inst. 2005;97(2):116–26.PubMedCrossRefGoogle Scholar
  14. 14.
    Early Breast Cancer Trialists’ Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355(9217):1757–70.CrossRefGoogle Scholar
  15. 15.
    Giordano SH, Kuo Y-F, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97(6):419–24.PubMedCrossRefGoogle Scholar
  16. 16.
    Harris EER, Correa C, Hwang W-T, Liao J, Litt HI, Ferrari VA, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(25):4100–6.CrossRefGoogle Scholar
  17. 17.
    •• Demirci S, Nam J, Hubbs JL, Nguyen T, Marks LB. Radiation-induced cardiac toxicity after therapy for breast cancer: interaction between treatment era and follow-up duration. Int J Radiat Oncol Biol Phys. 2009;73(4):980–7. This systematic review highlights the reduced rate of cardiovascular disease morbidity associated with modern radiation techniques. The influence of older radiation techniques on cardiovascular morbidity and mortality is also highlighted.Google Scholar
  18. 18.
    Hooning MJ, Botma A, Aleman BMP, Baaijens MHA, Bartelink H, Klijn JGM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99(5):365–75.PubMedCrossRefGoogle Scholar
  19. 19.
    de Graaf H, Dolsma WV, Willemse PH, van der Graaf WT, Sleijfer DT, de Vries EG, et al. Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer. Br J Cancer. 1997;76(7):943–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979;91(5):710–7.CrossRefGoogle Scholar
  21. 21.
    Doyle JJ, Neugut AI, Jacobson JS, Wang J, McBride R, Grann A, et al. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. Int J Radiat Oncol Biol Phys. 2007;68(1):82–93.PubMedCrossRefGoogle Scholar
  22. 22.
    Højris I, Sand NPR, Andersen J, Rehling M, Overgaard M. Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiother Oncol. 2000;55(2):163–72.CrossRefGoogle Scholar
  23. 23.
    McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson N-O, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2011;100(2):167–75.CrossRefGoogle Scholar
  24. 24.
    Paszat L, Mackillop W, Groome P, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol. 1998;16(8):2625–31.PubMedGoogle Scholar
  25. 25.
    Gagliardi G, Lax I, Rutqvist LE. Partial irradiation of the heart. Semin Radiat Oncol. 2001;11(3):224–33.PubMedCrossRefGoogle Scholar
  26. 26.
    Haybittle JL, Brinkley D, Houghton J, A’Hern RP, Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ (Clin Res Ed). 1989;298(6688):1611–4.CrossRefGoogle Scholar
  27. 27.
    Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Møller H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer. 2007;7(1):9.PubMedCrossRefGoogle Scholar
  28. 28.
    Darby S. Research pointers: Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ. 2003;326(7383):256–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Pistevou-Gompaki K, Hatzitolios A, Eleftheriadis N, Boultoukas E, Ntaios G, Andronikidis I, et al. Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer. Ther Clin Risk Manag. 2008;4(6):1359–62.PubMedGoogle Scholar
  30. 30.
    Nixon A, Manola J, Gelman R, Bornstein B, Abner A, Hetelekidis S, et al. No long-term increase in cardiac-related mortality after breast- conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998;16(4):1374–9.PubMedGoogle Scholar
  31. 31.
    Paszat LF, Vallis KA, Benk VMA, Groome PA, Mackillop WJ, Wielgosz A. A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2007;82(3):294–300.CrossRefGoogle Scholar
  32. 32.
    Taylor CW, Nisbet A, McGale P, Darby SC. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys. 2007;69(5):1484–95.PubMedCrossRefGoogle Scholar
  33. 33.
    Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98.PubMedCrossRefGoogle Scholar
  34. 34.
    Petersen C, Würschmidt F. Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist? Breast Care (Basel, Switzerland). 2011;6(5):369–74.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Cardiovascular Physiology and Rehabilitation LaboratoryUniversity of British ColumbiaVancouverCanada

Personalised recommendations